Dr. Ahmed Ahmed, M.D.
What this data tells you about Dr. Ahmed
Dr. Ahmed Ahmed is a cardiovascular disease in Webster, TX, with 20 years in practice. Based on federal Medicare data, Dr. Ahmed performed 6,154 Medicare services across 3,671 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahmed received a total of $3,372 from 30 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,007 | $95 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test | 596 | $42 | $250 |
| Advance care planning consultation, first 30 min | 582 | $63 | $300 |
| Electrocardiogram (EKG), 12-lead | 511 | $11 | $61 |
| Hospital follow-up visit, moderate complexity | 388 | $63 | $212 |
| Echocardiogram, transthoracic | 295 | $122 | $609 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 295 | $31 | $160 |
| Ultrasound of both sides of head and neck blood flow | 292 | $107 | $395 |
| Ultrasound of leg arteries or artery grafts | 288 | $134 | $380 |
| Ultrasound study of arm and leg arteries | 282 | $38 | $147 |
| Remote patient monitoring management, 20 min/month | 194 | $39 | $200 |
| Remote patient monitoring device, 30 days | 185 | $39 | $200 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 165 | $57 | $278 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 145 | $646 | $829 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 144 | $1,976 | $6,000 |
| Nuclear medicine study of heart muscle blood flow by pet | 144 | $149 | $550 |
| Initial hospital admission, high complexity | 97 | $134 | $582 |
| EKG interpretation and report | 85 | $7 | $28 |
| New patient office visit (45-59 min) | 83 | $113 | $463 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 64 | $20 | $81 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 64 | $688 | $2,000 |
| Limited ultrasound scan behind abdominal cavity | 46 | $48 | $321 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 40 | $86 | $310 |
| Infusion, normal saline solution, 250 cc | 34 | $1 | $50 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $362 | $1,132 |
| Injection of drug or substance into vein | 21 | $31 | $158 |
| Injection of additional new drug or substance into vein | 21 | $13 | $66 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 21 | $229 | $292 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 16 | $40 | $123 |
| Programming of dual lead pacemaker system | 15 | $59 | $129 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $87 | $311 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ahmed is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmed experienced with office visit, established patient (30-39 min)?
Does Dr. Ahmed receive payments from pharmaceutical companies?
How do Dr. Ahmed's costs compare to other cardiovascular diseases in Webster?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology